| Ticker: | BTMD |
| Current Price: | $1.13 |
| % Daily Change: | 8.65% |
| Volume (1,000s): | 144.76 |
| Average Volume (1,000s): | 277.67 |
| Market Cap (M): | $49.84 |
| 1/2/2024 Price: | $6.20 |
| Change Since Inception: | -81.77% |
biote Corp.
1875 W. Walnut Hill Ln #100
Irving, TX 75038
United States
Since its founding in 2012, biote Corp. has transformed the hormone optimization landscape from its headquarters in Irving, Texas. The company specializes in training physicians and nurse practitioners to treat hormonal imbalances in both men and women using bioidentical hormone replacement pellet therapy. By focusing on this specific clinical niche, biote helps medical professionals provide a more targeted and effective approach to patient wellness.
To support these providers, the company offers the Biote Method, an end-to-end platform that streamlines the business side of hormone optimization. This system provides practitioners with the necessary education, training, and certification to master the technical aspects of pellet therapy. Furthermore, biote equips its certified partners with proprietary practice management and inventory software. This technology allows clinicians to order, track, and manage their product supplies while handling the administrative demands of a busy medical office.
Beyond training and software, the company also provides the physical tools required for successful treatment. biote sells its own line of branded dietary supplements and sterile pellet insertion kits designed for both male and female patients. In addition to these medical supplies, the company offers digital and point-of-care marketing support to help practitioners grow their visibility. Ultimately, biote delivers a comprehensive ecosystem that combines clinical expertise with the operational and marketing resources needed to build a thriving practice.